结核模拟转移性神经内分泌肿瘤双示踪剂PET/CT进展一例
本文报道一例原发灶不明的转移性神经内分泌肿瘤老年女性,接受5周期[177Lu]Lu-DOTATATE PRRT后达部分缓解。随访中[68Ga]Ga-DOTATATE与[18F]FDG PET/CT显示新发FDG高代谢、低度SSTR表达的颈部淋巴结链延伸至纵隔,怀疑疾病进展或第二原发肿瘤,淋巴结组织病理学证实为结核性肉芽肿性炎症。
要点
- 双示踪剂PET/CT新发摄取增高需鉴别结核等感染性病变。
- 结核可表现为FDG高代谢且低度SSTR表达,模拟肿瘤进展。
- 改变治疗决策前应行组织学确认。
核心结论
- 结核是双示踪剂PET/CT假阳性及模拟神经内分泌肿瘤进展的潜在原因。
研究设计与样本
- 病例报告:一例原发灶不明的转移性神经内分泌肿瘤老年女性,接受5周期[177Lu]Lu-DOTATATE PRRT后达部分缓解。
主要发现
- [68Ga]Ga-DOTATATE与[18F]FDG PET/CT随访显示新发FDG高代谢、低度SSTR表达的颈部淋巴结链延伸至纵隔。
- 淋巴结组织病理学显示肉芽肿性炎症,符合结核。
临床怎么用
- 对双示踪剂PET/CT新发阳性病灶,在改变治疗管理前应行组织学确认以排除结核等假阳性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
False-positive findings on molecular imaging can pose significant diagnostic dilemmas in oncological cases. We report an elderly woman with metastatic neuroendocrine tumor of unknown primary who underwent 5 cycles of [177Lu]Lu-DOTATATE PRRT and achieved a partial response. On follow-up, [68Ga]Ga-DOTATATE and [18F]FDG-PET/CT scans demonstrated a new-onset FDG avid-hypermetabolic, low-grade SSTR-expressing cervical lymph node chain extending into the mediastinum, raising concern for disease progression or a second malignancy. Histopathology of the lymph nodes revealed granulomatous inflammation consistent with tuberculosis. This case highlights tuberculosis as a potential cause of false-positive dual-tracer PET positivity and the need for histologic confirmation before changing the management.
引用
- Bagasariya R, Sonavane S, Basu S, et al. Tuberculosis Mimicking Tumor Progression on Dual-tracer 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Neuroendocrine Tumor of Unknown Primary: A Potential Imaging Pitfall in Neuroendocrine Tumor Surveillance. Clin Nucl Med. 2026. PMID: 42710084. doi:10.1097/RLU.0000000000006583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。